Bausch + Lomb (B+L) recently announced it has received 510(k) clearance from the U.S. FDA for Vitesse™ — reportedly the first and only hypersonic, 100 percent open port vitrectomy system.
Vitesse features a single lumen design with a fixed open-port for consistent flow. It reportedly creates a highly-localized tissue liquification zone to liquefy the vitreous at the edge of the port before aspiration. According to B+L, vitreous removal is currently performed with a guillotine style vitrectomy cutter. This pneumatically driven vitrectomy cutter employs a needle-inside-a-needle design to perform a guillotine cut of the vitreous which is then aspirated.
This new technology will reportedly be featured exclusively on the new Stellaris Elite™ Vision Enhancement System.
Click here to read the full press release.
Like what you read? Follow OphthalmologyWeb to keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.